Rezai, Keyvan <br/><br/>
Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Dec 2011 
 - 1529-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-011-1650-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Lapatinib<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Models, Biological<br/>Quinazolines--administration & dosage<br/>Vinblastine--administration & dosage<br/>Vinorelbine